NewsfeedFollowed Companies

Myriad Genetics's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Myriad Genetics is a pharmaceutical company that researches and commercializes molecular diagnostic tests and equipment ... Read more

Based on data from Myriad Genetics's latest SEC filings

Annual Revenue

Based on data from Myriad Genetics's latest SEC filings

Employees

Mark C. Capone's photo - President & CEO of Myriad Genetics

President & CEO

Mark C. Capone

CEO Approval Rating

84/100

OVERVIEW

Founded:

1991

Headquarters:

Salt Lake CityUtah

Status:

PublicIndependent Company of NYSEMYGN

Industry Sector:

Biotechnology

SIC Code:

2834NAICS listing »

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Color a competitor of Myriad Genetics?

I don't know

Trending News for Myriad Genetics and Myriad Genetics's Competitors

January 23, 2020

Unique Finance

Myriad Submits sPMA for myChoice® CDx with Zejula® in First-Line Platinum Responsive Advanced Ovarian Cancer

Email Print Friendly Share SALT LAKE CITY, Jan. 22, 2020 (GLOBE NEWSWIRE) - Myriad Genetics, Inc. (NA... See more »

January 24, 2020

Entrepreneur

23andMe Lays Off 100 Workers Amid Shrinking Demand for DNA Tests

It's not the hot market the company predicted.... See more »

January 23, 2020

Pharmabiz

Quest Diagnostics buys specialty genetic testing company, Blueprint Genetics

Quest Diagnostics, the world's leading provider of diagnostic information services, announced that it... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Ambry is perceived as one of Myriad Genetics's biggest rivals. Ambry's headquarters is in Aliso Viejo, California, and was founded in 1999. Ambry operates in the Biotechnology industry. Ambry generates 23% of Myriad Genetics's revenue.

Foundation Medicine has been one of Myriad Genetics's top competitors. Foundation Medicine is a Private company that was founded in 2010 in Cambridge, Massachusetts. Foundation Medicine operates in the Biotechnology industry. Compared to Myriad Genetics, Foundation Medicine has 1,544 fewer employees.

MolecularMD is Myriad Genetics's #3 rival. MolecularMD was founded in Portland, Oregon} in 2005. MolecularMD is in the Biotechnology industry. Compared to Myriad Genetics, MolecularMD generates $825.1M less revenue.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Mark C. Capone

President & CEO

- -
2,206
$249.4K
$835.1M
1

Aaron Elliott

CEO

78/100
795
- -
$200M
2

Cindy Perettie

CEO

70/100
535
$165.5M
$541.1M
3

Dan Snyder

President & CEO

79/100
125
$19.1M
$10M
4

Anne Wojcicki

Co-Founder & CEO

75/100
683
$877.7M
$475M
5

Thomas H. Adams

Chairman & CEO

90/100
53
$50M
$ < 1M
6

Othman Laraki

Co-Founder & CEO

72/100
71
$149.4M
$10M
7

Tommi Lehtonen

Co-Founder & CEO

84/100
150
$19.9M
$17.7M
8

CEO

- -
846
$90.2M
$441.9M
9

Bennett Greenspan

Founder & CEO

67/100
120
- -
$20M
10

David D. Halbert

Chairman & CEO

96/100
370
$150M
$8.9M
The top 10 competitors in Myriad Genetics' competitive set are Ambry, Foundation Medicine, MolecularMD, 23andMe, Trovagene, Color, Blueprint Genetics, Genomic Health, Gene by Gene and Caris. Together they have raised over 1.5B between their estimated 3.8K employees. Myriad Genetics has 2,206 employees and is ranked 1st among it's top 10 competitors. The top 10 competitors average 541.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$835.1M

Myriad Genetics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 232.7M. Over the last four quarters, Myriad Genetics's revenue has decreased by 14.1%. Specifically, in Q3 2019's revenue was $186.3M; in Q2 2019, it was $215.4M; in Q1 2019, it was $216.6M; in Q4 2018, Myriad Genetics's revenue was $216.8M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Counsyl, Inc.

May 2018

Source »
$375M
Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.
Assurex Health, Inc.

Aug 2016

Source »
$225M
AssureRx Health is a precision medicine company that specializes in pharmacogenomics for behavioral health and chronic pain.
Sividon Diagnostics

May 2016

Source »
$38.9M
Sividon Diagnostics develops and commercializes genomic-based diagnostic test for breast cancer treatment.
Crescendo Bioscience, Inc.

Feb 2014

Source »
$270M
Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases.

These are all the companies that Myriad Genetics has acquired. Myriad Genetics has acquired 4 companies and its latest acquisition was Counsyl, Inc. in May 2018. Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.

Myriad Genetics Funding History

Since Myriad Genetics was founded in 1991, it has participated in 1 round of funding. In total Myriad Genetics has raised $249.4K. Myriad Genetics' funding round was on Feb 2019 for a total of $249.4K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Feb 2019
$249.4K
-

Total Funding: $249.4K

Since Myriad Genetics was founded in 1991, it has participated in 1 round of funding. In total Myriad Genetics has raised $249.4K. Myriad Genetics' funding round was on Feb 2019 for a total of $249.4K

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

RainDance Technologies is a developer and provider of microdroplet-based solutions for the early detection of cancer and other diseases.
$16.5M
Mar 02, 2014
Series E
Jan 01, 2017
RainDance Technologies is a developer and provider of microdroplet-based solutions for the early detection of cancer and other diseases.
$41.9M
Apr 11, 2013
Series E
Jan 01, 2017

These are all the companies that Myriad Genetics has invested in. Myriad Genetics has invested 4 companies and its latest investment was Counsyl, Inc. in May 2018. Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.

Myriad Genetics News

January 7, 2020Zacks

Myriad Genetics' GUIDED Clinical Trial Outcome Encouraging

The result of this clinical trial is a major stride forward in Myriad Genetics' (MYGN) commitment tow... See more »
January 6, 2020Benzinga

Myriad Genetics to Present at the J.P. Morgan 2020 Healthcare Conference

SALT LAKE CITY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in mo... See more »
January 1, 2020BioPortfolio

Myriad Genetics Inc MYGN Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $106

Myriad Genetics Inc MYGN Financial and Strategic SWOT Analysis Review provides you an indepth strateg... See more »
December 31, 2019Zacks

Myriad Genetics' Cancer Companion Diagnostic Test Gets FDA Nod

Myriad Genetics (MYGN) expands the use of BRACAnalysis CDx as a companion diagnostic test for metasta... See more »
December 28, 2019Clinical Lab Products

GeneSight Psychotropic Test Improves Clinical Outcomes for People with Depression

A new analysis of data from the Guided trial shows that GeneSight test results led to statistically s... See more »
December 4, 2019MarketWatch

Myriad shares fall despite positive results on prenatal test

Shares of Myriad Genetics dropped 3% in premarket trading after the diagnostics maker said its Preque... See more »
December 3, 2019MarketScreener

Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium

(marketscreener.com) SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:... See more »

Myriad Genetics Blogs

July 11, 2019Myriad Genetics Blog

1 in 5 Minorities Struggle with Depression in the United States

July is Minority Mental Health Awareness Month. It is estimated that 1 in 5 minorities struggle with... See more »
February 8, 2019Myriad Genetics Blog

Myriad Genetics 2019 Facts at a Glance

Myriad Genetics has been in business for more than 27 years and we are a global leader in personalize... See more »
January 10, 2019Myriad Genetics Blog

Myriad Women’s Health: Empowering women and their families to make critical and timely healthcare decisions

Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s... See more »
January 10, 2019Myriad Genetics Blog

Myriad Women's Health: Empowering women and their families to make critical and timely healthcare decisions

Counsyl, Inc. has combined with Myriad Genetics' Preventive Care business unit to form Myriad Women's... See more »
October 1, 2018Myriad Genetics Blog

Genetic Testing Helps Personalize Breast Cancer Treatment Decisions

October is breast cancer awareness month and according to the American Cancer Society, 1 in 8 U.S. wo... See more »
July 12, 2018Myriad Genetics Blog

Helping to Realize the Benefits of Personalized Medicine for Minority Populations

The biomedical innovation now happening in the molecular diagnostics industry is making it possible f... See more »
May 15, 2018Myriad Genetics Blog

GeneSight: Helping Patients with Depression

Mental Health Month, Depression and GeneSight®  The GeneSight® genetic test has produced exciting ... See more »

Myriad Genetics Press Releases

October 31, 2019GlobalNewswire

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MO, MYGN, UBER and TEUM

NEW YORK, Oct. 31, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints... See more »
August 22, 2019StreetInsider

Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention

More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic TestingSALT LAKE CITY, Aug.... See more »
May 9, 2019GlobeNewswire

New Publication Shows the EndoPredict® Test Identifies Women with Early-Stage Breast Cancer Who Can Forgo Extended Endocrine Therapy

New Study Finds Approximately 62 Percent of Women May Not Need Extended Endocrine Therapy Five Years ... See more »
May 7, 2019StreetInsider

Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results

SALT LAKE CITY, May 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the... See more »
May 7, 2019GlobeNewswire

Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results

SALT LAKE CITY, May 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, "Myriad" or the... See more »
May 1, 2019GlobeNewswire

Myriad Announces Coverage Decision by Kroger® Prescription Plans for GeneSight®

Agreement Also Includes In-store Interventions at Kroger Pharmacies NationwideAgreement Also Includes... See more »
April 4, 2019StreetInsider

Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership

SALT LAKE CITY, April 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in ... See more »

Myriad Genetics Videos

November 19, 2019Myriad Genetics Youtube Channel

"Ed Hoppe - Prolaris Test for Prostate Cancer" on YOUTUBE

See more »
November 19, 2019Myriad Genetics Youtube Channel

"Hoppe Family Story - myRisk Hereditary Cancer" on YOUTUBE

See more »
November 1, 2019Myriad Genetics Youtube Channel

"What you need to know about genetics and your risk for hereditary cancer." on YOUTUBE

See more »
September 23, 2019Myriad Genetics Youtube Channel

"#WeAreMyriad 2020" on YOUTUBE

See more »
May 20, 2019Myriad Genetics Youtube Channel

"Myriad Genetics at the 2019 American Society of Clinical Oncology annual meeting" on YOUTUBE

See more »
May 17, 2019Myriad Genetics Youtube Channel

"Employee Spotlight: Fred" on YOUTUBE

See more »
April 25, 2019Myriad Genetics Youtube Channel

"DNA Day 2019 - Myriad Genetics" on YOUTUBE

See more »

Social Statistics

Headquarters

320 Wakara Way

Salt Lake City, Utah84108

800-469-7423

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Myriad Genetics is a pharmaceutical company that researches and commercializes molecular diagnostic tests and equipment for rare diseases. Myriad Genetics was founded in 1991. Myriad Genetics' headquarters is located in Salt Lake City, Utah, USA 84108...

CEO

Myriad Genetics's President & CEO, Mark C. Capone, currently has an approval rating of 84%. Myriad Genetics's primary competitors are Ambry, Foundation Medicine & MolecularMD.

Website

myriad.com

Frequently Asked Questions about Myriad Genetics

  1. When was Myriad Genetics founded?

    Myriad Genetics was founded in 1991

  2. Who is Myriad Genetics's CEO?

    Myriad Genetics's CEO is Mark C. Capone

  3. How much revenue does Myriad Genetics generate?

    Myriad Genetics generates $835.1M in revenue

  4. How much funding does Myriad Genetics have?

    Myriad Genetics has historically raised $249.4K in funding

  5. Where is Myriad Genetics's headquarters?

    Myriad Genetics's headquarters is in Salt Lake City Utah, USA

  1. How many employees does Myriad Genetics have?

    Myriad Genetics has 2,206 employees

  2. What sector does Myriad Genetics operate in?

    Myriad Genetics is in Biotechnology

  3. Who are Myriad Genetics's competitors?

    Myriad Genetics's top competitors are Ambry, Foundation Medicine, MolecularMD

  4. Who has Myriad Genetics invested in?

    Myriad Genetics's has invested in companies such as RainDance, RainDance
Stay up-to-date with the latest news on Myriad Genetics